Do you want to read an article? Please log in or register.
Type 2 Diabetes Genetic Variants and Risk of Diabetic Retinopathy.
Retinal Diseases
Related content
Retinal DiseasesFurther Publications
Higher Serum Uric Acid Levels Are Associated With an Increased Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes Patients
Invest Ophthalmol Vis Sci
Hu Y, Chan Z, Li C, Shi Y, She X, Gu C, Wang Y, Zhou C, Zhao S, Zheng Z, Chen H
doi: 10.1167/iovs.62.4.23
Retinal Diseases
Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort
Br J Ophthalmol
Smith JJ, Wright DM, Stratton IM, Scanlon PH, Lois N
doi: 10.1136/bjophthalmol-2020-318570
Macular DiseasesRetinal Diseases
Optical Coherence Tomographic Angiography in Type 2 Diabetes and Diabetic Retinopathy
JAMA Ophthalmol.
Ting DSW, Tan GSW, Agrawal R, Yanagi Y, Sie NM, Wong CW, San Yeo IY, Lee SY, Cheung CMG, Wong TY
doi: 10.1001/
Retinal Diseases
Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes
BMC Ophthalmol
Chen D, Sun X, Zhao X, Liu Y
doi: 10.1186/s12886-020-01713-5
COMMENTED
Cataracts
Visual acuity outcomes after cataract surgery in type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study
★ 2
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Br J Ophthalmol
Lee D, Agron E, Keenan T, Lovato J, Ambrosius W, Chew EY, ACCORD Eye Study Research Group.
doi: 10.1136/bjophthalmol-2020-317793
Retinal Diseases
Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging With Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy
JAMA Ophthalmol.
Aiello LP, Odia I, Glassman AR, Melia M, Jampol LM, Bressler NM, Kiss S, Silva PS, Wykoff CC, Sun JK, Diabetic Retinopathy Clinical Research Network
doi: 10.1001/jamaophthalmol.
COMMENTED
Blindness and Vision Impairment
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
★ 2
Recommended and commented by
Prof. Dr emer. Josef Flammer, Faculty Member
BMJ
Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, Tunnicliffe D, Ruospo M, Natale P, Saglimbene V, Nicolucci A, Johnson DW, Tonelli M, Rossi MC, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque LI, Lloyd A, Ahmad N, Liu Y, Tiv S, Millard T, Gagliardi L, Kolanu N, Barmanray RD, McMorrow R, Raygoza Cortez AK, White H, Chen X, Zhou X, Liu J, Rodríguez AF, González-Colmenero AD, Wang Y, Li L, Sutanto S, Solis RC, Díaz González-Colmenero F, Rodriguez-Gutierrez R, Walsh M, Guyatt G, Strippoli GFM
doi: 10.1136/bmj.m4573
Retinal Diseases
Retinal venular oxygen saturation is associated with non-proliferative diabetic retinopathy in young patients with type 1 diabetes
Acta Ophthalmol
Veiby NCBB, Simeunovic A, Heier M, Brunborg C, Saddique N, Moe MC, Dahl-Jørgensen K, Petrovski G, Margeirsdottir HD
doi: 10.1111/aos.15018
RECOMMENDED
Retinal Diseases
Severity of diabetic retinopathy and the risk of future cerebrovascular disease, cardiovascular disease, and all-cause mortality
★ 2
Recommended by
Prof. Dr emer. Josef Flammer, Faculty Member
Ophthalmology
Modjtahedi BS, Wu J, Luong TQ, Gandhi NK, Fong DS, Chen W
doi: 10.1016/j.ophtha.2020.12.019